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SYNOPSIS 
 
Cell activation by stressors is characterised by a sequence of detectable phenotypic cell 
changes. The strength of a given stimulus induces modifications in the activity of membrane 
phospholipids transporters and calpains, which leads to phosphatidylserine exposure, 
membrane blebbing and the release of microparticles(nanoscale membrane vesicles).This 
vesiculation could be considered as a warning signal that may be followed, if the stimulus is 
maintained, by cell detachment-inducedapoptosis. 
In this study, plasminogenincubated ontoadherent cells is activated into plasmin by 
constitutively expressed tPA or uPA. Plasmin formed on the cellular membrane then induces 
an unique response characterized by membrane blebbing and vesiculation.Hitherto unknown 
for plasmin, these membrane changes are similar to those induced by thrombin on platelets. If 
plasmin formation evolves, matrix proteins are then degraded, cells loseattachment and enter 
the apoptotic process, characterized by DNA fragmentation and electron microscopy features. 
This sequence of events was experimentally documented atall these stages. Since other 
proteolytic or inflammatory stimuli may evoke similar responses by distinct adherent cells, 
this sequence can be applied to distinguish activated adherent cells from cells entering the 
apoptotic process.This is a major definition crucial to the identification of mediators, 
inhibitors and potential therapeutic agents. 
 
 
Key words: Plasminogen, membrane blebbing, microparticles, apoptosis, electron 
microscopy 
 
Abbreviations used: 
Microparticles: MPs  
Urokinase type plasminogen activator: uPA 
Tissue-type plasminogen activator: tPA 
Extracellular matrix: ECM 
ε-aminocaproic acid: ε-ACA 
Tetrazolium salt 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide: MTT 
Carboxypeptidase B: CpB 
4’, 6-diamino-2-phenylindole: DAPI 
Terminal Deoxynucleotidyltransferase-mediated dUTP Nick End Labeling: TUNEL  
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INTRODUCTION 
 
Cell response to a number of stressors and inflammatory mediators iskey to maintenance of 
tissue homeostasis. Initial cell activation may evolve to apoptosis depending on the type and 
intensity of stimuli [1]. Early manifestations of this cell activation process are the formation 
of membrane blebs and the shedding of nanoscale membrane fragments known and 
designated hereafter as microparticles(MPs, 0.1 to 1 µm) [2]. This phenomenon is also an 
early event of cells entering apoptosis. Since the first discovery of MPs in a platelet-free 
plasma [3, 4], the most well known cellular MPs are those of platelet, leukocyte, erythrocyte 
and endothelial cell origin found in circulating blood [5]. A number of studies have 
demonstrated that stimulation of these cells is followed by the characteristic features of cell 
activation: increased levels of cytoplasmic calcium associated to exposure of 
phosphatidylserine and activation of calpains (EC 3.4.22)[6]. The increase in intracellular 
calcium induces a disordered state in the concerted activity of membrane transporter proteins 
(flippases, floppase and scramblases) that maintain the phospholipids asymmetry of quiescent 
cells[7, 8]. As a result, the procoagulant phosphatidylserine is translocated from the inner 
leaflet to the external leaflet of the membrane. The activated calpains cleave cytoskeleton 
filaments and thereby facilitate membrane blebbing and shedding of MPs. In addition to their 
procoagulant activity, MPs carry at their surface identity antigens that characterize their 
cellular origin. Since they also convey proteolytic glycoproteins, growth factor or 
inflammatory mediators, they are currently considered as a storage pool of bioactive effectors 
[9]. The proteolytic mediators that have been identified include the plasminogen activation 
system and the matrix metalloproteases(EC 3.4.24) [10-13]. 
The plasminogen activation system is involved in fibrinolysis and in pericellular proteolysis 
[14]. Finely regulated, cellular plasminogen activation plays an essential role in extracellular 
matrix (ECM) remodelling[1], cell migration [15] and survival [16].The central mechanism is 
the transformation of plasminogen into plasmin(EC 3.4.21.7), the active enzyme, at cell 
membranes and ECM or atthe surface of fibrin, by the urokinase- or the tissue-type- 
plasminogen activator, uPA (EC 3.4.21.73) or tPA (EC 3.4.21.68), respectively. MPs function 
as a catalytic surface for plasmin formation by providing both plasminogen activators and 
plasminogen binding sites[10]. Interestingly, the uPA system of MPs also participates in the 
formation of plasmin at the surface of platelets, fibrin or the ECM via a 
fibrinolytic/proteolytic cross-talk mechanism recently described [17]. Thrombin (EC 3.4.21.6), 
another serine protease, is known to induce the release of MPs by platelets, but the plasmin 
potential to induce vesiculation is not known as yet. 
Beyond activation-dependant release of MPs, the survival of cells within structural-functional 
units involving tissue specific components and the microvasculature (e.g. neurovascular unit, 
glomerulus and pulmonary alveolus), depends on dynamic cell-matrix interactions that ensure 
their adhesion to the substratum and tissue cohesion. Thus, in the absence of any ECM 
interaction, human endothelial cells rapidly enter apoptosis [18]. Accordingly, excessive 
proteolysis of the ECM by cells that express a plasminogen activator system results in loss of 
cell anchorage and apoptosis [19], a phenomenon that may be of relevance in pathological 
situations in vivo[20]. Discerning the steps of this cell activation that may induce apoptosis is 
therefore a key to identify mediators, inhibitors and potential therapeutic targets. 
We unveil in this report that plasmin provokes the release of cell-derived MPsand proposea 
sequence of events initiated byplasminogen activation on adherent cellsand spanning from 
early blebbing and vesiculationto subsequent cell detachment and apoptosis/survival.Because 
other proteolytic or inflammatory stimuli may evoke similar responses by distinct adherent 
cells, this mechanisticproceduremaybe applied to distinguish activated adherent cells from 
cells entering the apoptotic process.  
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EXPERIMENTAL 
 
Reagents and proteins 
Human Glu-plasminogen used in this study waspurified and characterized as described [21] 
and was over 99% pure as assessed by SDS-PAGE and by amino-terminal sequence analysis. 
Plasmin was prepared by activation of Glu-plasminogen with immobilized uPA according 
toWiman and Wallen[22]with modifications. Rabbit anti-mouselaminin polyclonal 
antibodywas kindly provided by H. P. Erickson (Duke University Medical Center, Durham, 
NC). The peroxidase-labelled monoclonal antibody directed against plasminogen kringle1 
(CPL15-PO) was prepared as described [19]. Active-site blocked plasmin (D-Val-Phe-Lys-
chloromethylketone, dihydrochloride, Pn-VFK) was prepared as described previously [16]. 
uPA(140 000iu/mg) and tPA (578 000iu/mg) (both over 99% single-chain form) were 
obtained from Biopool AB (Umea, Sweden) and Abbot (Chicago, Il, USA), 
respectively.Aprotinin was a kind gift from Bayer HealthCare AG (Leverkusen, Germany). 
Glutamine, foetal calf serum and DMEM-Ham's F-12 medium wereobtained from Invitrogen 
(Carlsbad, CA, USA). The chromogenic substrate selective for plasmin (methylmalonyl)-
hydroxyprolylarginine-para-nitroaniline (CBS0065) was from Stago (Asnieres, France). The 
plasmin inhibitor VFK was from calbiochem (Darmstadt, Germany). The lysine analogue -
aminocaproic acid (-ACA), the tetrazolium salt 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromide (MTT), dimethylsulfoxide (DMSO), carboxypeptidase B (CpB, porcine 
pancreas),4’, 6-diamino-2-phenylindole (DAPI) were from Sigma (St-Louis, MO, USA). The 
terminal Deoxynucleotidyltransferase-mediated dUTP Nick End Labeling (TUNEL) was from 
Roche Applied Science (Neuilly sur Seine, France). 
 
Identification of cell plasminogen activators 
Chinese hamster ovary cells (CHO-K1 cells, American Type Culture Collection CCL-61, 
fibroblast phenotype), human embryonic kidney cells (HEK-293, [23]) and human 
microvascular endothelial cells (HMEC-1, [24]) were used as prototype adherent cells. Cells 
were grown in a 37°C humidified atmosphere of 5% CO2 using DMEM-Ham's F-12 medium 
(CHO-K1 cells) or RPMI medium (HEK-293 and HMEC-1 cells) supplemented with 2 mM 
L-glutamine and 10% foetal calf serum. Cells were then seeded in 96 or 24 wells plates, 
depending on experiments. Fibrin autography following SDS-PAGE was performed as 
described previously [25]. Briefly, cells were lysed in 100 mMTris-HCl buffer, pH 8.1, 
containing 1% Triton X-100. Proteins in cell lysates (100 µg) and reference proteins (10 µL 
of tPA 5 nM, uPA 1 nM and plasmin 500 nM) were electrophoresed in a 8% polyacrylamide 
gel under non-reducing conditions. SDS was then exchanged with 2.5% Triton X-100. After 
washing-off excess Triton X-100 with distilled water, the gel was carefully overlaid on a 1% 
agarose gel containing 1 mg/mL of bovine fibrinogen, 100 nM plasminogen and 0.2 NIH 
unit/mL of bovine thrombin. Zymograms were allowed to develop at 37°C during 24 h and 
photographed at regular intervals using dark-ground illumination. Active proteins in cell 
lysates were identified by reference to the migration of known markers (uPA, tPA, 
plasmin).To verify the activator identity, cell lysates were incubated with a polyclonal 
antibody directed against tPA or uPA and their residual activity detected by radial diffusion 
on fibrin-agarose gels. 
 
Cell activation by plasmin 
Cells were incubated with Glu-plasminogen (1µM) at 37°C, in the presence of 0.75 mM of 
CBS0065, a plasmin selective chromogenic substrate. In parallel experiments, the effect of 
various inhibitors (-ACA, a lysine analogue that blocks plasminogen binding to cells; CpB, 
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an exopeptidase that cleaves C-ter Lys residues on cells; aprotinin, a serine-protease inhibitor 
with restricted specificity) on plasminogen activation (1 µM) was determined in the presence 
of 0.75 mM of CBS0065. 
Kinetics of plasmin formation was followed by measuring the release of p-nitroaniline from 
the chromogenic substrate, detected as a change in absorbance (A405nm / min), using a 
multiwell plate reader (MX5000, Dynex) thermostated at 37 °C. Rates of plasmin formation 
were calculated from slopes of A405nmversus time. Initial rates were computer-calculated at the 
inflexion point of the curve by non-linear least square analysis, and were fit to the michaelis-
menten equation considering a non-specific component proportional to plasminogen 
concentration. 
 
 
 
 
Detection of cell blebbing and release of microparticles by activated cells  
Supernatants of activated cells,collected at different time points during plasminogen 
activation, were supplemented with 2% glutaraldehyde to fix detached cells 
beforecytospinning at 800 g for 5 min (cytospinThermo Fisher Scientific, USA) on small 
Thermanox (NUNC, USA) coverslips. These coverslips support cells all along the 
preparation until the end of polymerization and embedding of the resin for electron 
microscopy. Rapidly after cytospinning, the Thermanoxcoverslips were transferred into a cap 
containing phosphate buffer. Cells were then rinsed 3 times in phosphate buffer (0.1M, pH 7.4) 
before and after post-fixation with 0.5% osmium tetroxide, dehydrated through a graded 
ethanol series (70% 2x, 95% 3x, 100% 4x) and finally embedded in epon resin. After 
polymerization, the coverslips were removed and ultrathin sections were stained with 2% 
uranyl acetate and lead citrate. All observations were performedwith a JEOL 1011 
transmission electron microscope. Images were acquired with a megaview III camera (SIS). 
 
Microparticle isolation 
MPs were isolated from culture medium conditioned by subconfluentadherent cells stimulated 
for 24 h with 1 µM plasminogen. Culture supernatants were collected and cleared from 
detached cells or large cell fragments by centrifugation at 1500 g for 15 min. The supernatants 
were then centrifuged at 20000g for 90 min at 4°C. PelletedMPs were washed twice using the 
same conditions and were suspended in phosphate-buffered saline.  
 
Determination of cell survival by the MTT method 
At indicated time intervalsduring plasminogen activation, the conditioned medium was 
carefully removed from a 96-well plate without disturbing the cell monolayer and replaced 
with 100 µL of 0.5 mg/mLMTT. The tetrazolium salt was transformed into formazan by the 
mitochondrial succinatedeshydrogenase of living cells. After 1 h at 37°C, excess MTT was 
removed and the formed crystals of formazan were dissolved in 100 µL of DMSO and 
colorimetrically detected at A550 nm. Absorbance readings are proportional to the number of 
living cells. The results are expressed as a percentage compared to control cells. 
 
TUNEL and DAPI staining 
After cytospinning of cell supernatants collected at different time intervalsof plasminogen 
activation, TUNEL was used to visualize DNA fragmentation. The cells were then 
counterstained with DAPI to visualize all nuclei. After washing, the slides were mounted and 
observed under an epifluorescence microscope. The TUNEL index was calculated as the 
percentage of TUNEL-positive nuclei relative to total DAPI-stained nuclei. 

V
max
Pg 
Km  Pg 
 k Pg 
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Western Blot 
Plasmin-activated cellsor MPswere lysed in 100 mMTris-HCl buffer, pH 8.1, containing 1% 
Triton X-100. Proteins in lysates (10 µg) were electrophoresed in an 8% polyacrylamide gel 
under reducing conditions. Proteins were transferred to PVDF membranes and revealed with 
primary specific antibodies (a sheep antibody directed against uPA, a rabbit antibody directed 
against laminin and a peroxidase-labelled monoclonal antibody directed against plasminogen 
kringle1)at proper concentrations and HRP-coupled secondary antibodies when indicated. 
 
Statistical analyses 
Data are expressed as mean ± standard error of the mean (SEM). The statistics were 
performed using nonparametric tests of Kruskall Wallis and of Mann Whitney (MYSTAT12 
software). Statistical significance was set at p < 0.05. 
 
 
RESULTS-DISCUSSION 
Cell membrane stability and functioning depend on coupling of the phospholipid asymmetric 
transbilayer to the cytoskeleton. In adherent cells, stability is further enhancedby coupling of 
integral membrane protein receptors (integrins) to ECM glycoproteins such as fibronectin, 
laminin, collagen, thrombospondins and tenascins that act as a scaffold surface for cell 
adhesion. They function as a mediator of cytoskeleton reorganization leading to formation of 
focal adhesions and intracellular signalling[26, 27] that direct cell growth, morphology, 
migration and anchorage-dependent survival [28]. Disruption of the transbilayerphospholipid 
asymmetry or disruption of ECM-integrin interactions by proteolysis or integrin antagonists 
for example, is associated with cell activation or pathologic conditions. Since they may have 
consequences on membrane cytoskeleton reorganization and on cell adhesion during tissue 
remodeling or in pathological proteolysis [20, 29, 30], we explored the possibility that 
plasmin formation on cells may induce these phenotypic cell changes. We provide here the 
first demonstration that plasmin generated at the surface of adherent cells induces an early 
response characterized by membrane blebbing and vesiculation, i.e., release of MPs. In 
addition, we show that plasmin proteolyses ECM proteins and thereby disruptinteractionswith 
cells that result in phenotypic changes characteristic of cell detachment and apoptosis. Thus, 
in agreement with previous reports [8, 31], localized decoupling of the cytoskeleton to the 
membrane results in formation of a bleb exposing phosphatidylserine [8] and loss of 
anchoring to the matrix results in reorganization of focal adhesion points and cell detachment 
[31]. Membrane blebs, MPs and cells activated or entering apoptosis express 
phosphatidylserine at the outer leaflet [6]. Fluorescent annexin A5 has been used to detect the 
exposed phosphatidylserine by flow cytometric analysis [32]. Since MPs may contaminate 
cell preparations [33], the annexin A5 binding assay cannot discriminate amongst cells or 
MPs expressing phosphatidylserine [34]. To better identify early morphological changes 
(membrane blebbing and vesiculation) before anchorage-depending survival of cells is 
compromised, we first determined the ability of cells to express plasminogen activators and 
then monitored plasmin formation and its effects on cell blebbing and survival.  
We demonstrate that CHO-K1 and HEK-293 cells express active tPA whereas HMEC-1 cells 
express uPA as indicated by the position of a fibrinolytic band similar to the migration of 
purified uPA or tPA detected by fibrin zymography (Fig. 1A, upper panel). Confirmation was 
obtained by inhibition of the fibrinolytic activity with specific antibodies as detected by radial 
diffusion on fibrin-agarose gels(Fig. 1A, lower panel). Unrelated antibodies had no effect on 
plasminogen activation(Fig. 1A, lower panel). Kinetics of plasmin formation (Fig. 1B) 
indicated that plasminogen incubated with cells were assembled at their surface and 
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transformed into plasmin in a time-, lysine- and dose-dependent manner until saturation 
(Fig.1C). Kinetic parameters were determined by fitting data to the Michaelis-Menten 
equation (Vmax [Pg] / (Km+[Pg])) + k[Pg]); Table 1). The calculated Km value is 
comparable to values obtained for tPA expressed by other cell types including endothelial 
cells[35] and neurons[16]. It is also comparable to values determined for the activation of 
plasminogen by tPA on fibrin (40 to 160 nM[36, 37],suggesting that the cell surface providesa 
similar plasminogen activation enhancement. Lysine-dependant specific plasminogen binding 
was indicated by inhibition of plasmin formation both with the lysine analogue -ACA that 
blocks the LBS of plasminogen, and with CpB that cleaves C-ter lysine residues from the cell 
surface. The activity of plasmin formed in situ was efficiently inhibited by aprotinin (Fig. 1D).  
 
Since thrombin, a serine protease like plasmin, induces membrane blebbing and platelet 
vesiculation, we explored the possibility that plasmin may induce a similar response on 
adherent cells. Membrane blebbing is a short-lived phenomenon observed at the very initial 
phase of cell stimulation that can only be visualized by electron microscopy. For that purpose, 
the early response of cells to plasmin formation was interrupted by glutaraldehyde fixation, 
thus allowing capture of multiple blebbing of the membrane and formation of numerous MPs 
that were about to be released by cells (Fig. 2). A small number of MPs could be detected in 
culture control conditions (Fig. 2A, Table 1). After incubation of cells with plasminogen, the 
number of MPs detected in the culture medium was dramatically increased, independently of 
the adherent cell type (Fig 2A). These MPs are around 300 nm in size and contain 
substructures having an electron density similar to that of cell cytoplasm, which are 
surrounded by a well-defined membrane (Fig 2B,C, D). This phenomenon was dependent on 
the activity of plasmin as indicated by its prevention in the presence of aprotinin (data not 
shown). Since plasmin was the onlyaprotinin-sensitive serine protease present in the culture 
supernatant (Fig. 1B), these results indicate that membrane blebbing is one of the early 
responses of cells to plasmin.MPs, that are released, carry the plasminogen activator of their 
parental cell (e.g. uPA for HMEC-1, Fig 3A) at their surface and plasmin(ogen) bound at the 
membrane (Fig 3B). These results confirm that MPs could be considered as potential 
messengers of proteolytic activity [9, 10]. 
 
As indicated above, the first and immediate consequence of cellular stimulation by plasmin is 
membrane blebbing followed by the release of MPs. The continuous formation of plasmin has 
other consequences on cell phenotype and behaviour, which are related to the proteolytic 
activity of plasmin on the substratum. Active plasmin proteolyses and degrades components 
of the ECM including laminin (Fig. 3C) and fibronectin[38]. In the absence of a substratum 
for anchorage, the cells became round (Fig. 4A) and gradually detached from their support as 
shown by the amount of residual living cells (MTT assay, Fig. 4B). After 48 h of incubation 
with plasminogen, the detached CHO-K1 cells entered the apoptotic process as suggested by 
DNA fragmentation observable by TUNEL (Fig. 4C, D).   
Electron microscopy allowed detailed observation of cell morphology and characteristic 
apoptotic changes (Fig. 5). In control cells, the nucleus membrane is clearly delimitated and 
the characteristics of normal cytoplasm are maintained including endoplasmic reticulum and 
mitochondria with their internal crests (Lower panel, Fig. 5A). In plasminogen-treated cells 
(Fig. 5B; 48 h), the nucleus shows chromatin condensation, the cytoplasm is disorganized, 
contains lysis vesicles and mitochondria become electron dense (Lower panel, Fig 5B). After 
72 h of stimulation, consequences of plasmin formation are dramatic: higher condensation and 
fragmentation of the chromatin (Fig. 5C).  
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To investigate the relation between plasmin formation and cell detachment, we used active-
site blocked plasmin, Pn-VFK (Fig.6A). As a consequence, Pn-VFK is unable to develop a 
proteolytic activity on ECM components, e.g. laminin (Fig. 3C). In the absence of ECM 
degradation, cells do not detach from their support and remain viable (Fig.6B). 
 
Altogether, these data indicate that upon plasmin formation, the proteolytic activity of this 
enzyme induces (1) at the cell level, membrane blebbing and vesiculation and (2) on matrix 
proteins, cell detachment-induced apoptosis. 
Conditioned medium from cell culture experiments and animal or human biological fluids (e.g. 
urine) or exudates (e.g. ascites, cyst fluid, and pleural effusion) contain detached cells that can 
be cytospun and processed for visualization of structural and morphological changes (Fig. 7). 
This procedure allows sequential identification of the initial state of cell activation before 
irreversible cell damage occurs, and further explores a more advanced state of cell injury 
characterized by nuclear and cytoplasmic abnormalities typical of apoptosis.  
The advantage of the proposed procedure is that early morphological changes (membrane 
blebbing and vesiculation) can be easily identified before anchorage-dependent survival of the 
cells is compromised[19, 32, 39-42]. In the absence of other morphological or structural 
modifications, these initial membrane changes indicate a reversible response to stimulation by 
stressors and can be used as indicators of cell stimulation/suffering. Another advantage is that, 
from the same culture supernatant or biological fluid, it could be possible to isolate (Fig. 2) 
and to analyze MPs(Fig. 3A, B). 
Finally, in vivo proteolytic-dependant degradation of ECM and apoptosis [43-45] may also be 
studied. In the case of human pathologies or animal experiments this mechanistic procedure 
has potential application for diagnostic purposes and in the follow up of disease progression 
and treatment.  
 
In conclusion, we show in this report that plasmin formed at the surface of adherent cells 
induces two responses(Fig. 7): (1) membrane blebbing and vesiculation (gray arrow)- the 
early response of adherent cells to proteolytic activation and (2) a delayed response 
characterized by cell detachment and apoptosis (black arrow). Investigation and analysis of 
this succession of events identifies the outcome of adherent cells in response to insults that 
may potentially shift from minimal structural changes (membrane blebbing and vesiculation) 
to apoptosis. This sequence may be operative in inflammatory processes like atherosclerosis 
[20] and in adherent cells derived from the central nervous system [16]. 
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FIGURE LEGENDS 
 
Figure 1. Identification of plasminogen activators and cellular activation of plasminogen. 
A.Fibrin-agarosezymography of CHO-K1, HEK-293and HMEC-1cells. The picture was 
taken after 24 h at 37 °C. The position of purified control references (100 pmol of plasmin: Pn, 
1 pmol of tPA and 0.2 pmol of uPA) is indicated on the left. CHO-K1 and HEK-293 
areshown to express active tPA whereas HMEC-1 express uPA, identified on the basis of their 
molecular mobility compared to references (Upper panel). Identity of the plasminogen 
activator was verified by inhibition of their proteolytic activity with specific antibodies () on 
radial diffusion fibrin-agarose gels (Lower panel). BKinetics of plasmin formation.Progress 
curves of Glu-plasminogen (0.125 and 1µM) activation by CHO-K1 cells.Plasmin formation 
was detected by measuring the release of p-nitroaniline(A405) as a function of time (n = 3). 
The effect of aprotinin (2 µM) on plasmin activity is shown at 1 µM plasminogen. 
Background activity in the absence of plasminogen was detected in presence (2 µM) or 
absence of aprotinin.C.Dose-dependent activation of plasminogen. CHO-K1, HEK-293 or 
HMEC-1 cells (10
5
 cells/well) were incubated with varying concentrations of Glu-
plasminogen (0 to 2 M) and 0.75 mM CBS0065. Kinetics of plasmin formation (A405/min) 
was followed by measuring the release of p-nitroaniline. Data were fitted to the Michaelis–
Menten equation. Non-specific activation (k[Pg] in the equation) is proportional to 
plasminogen concentration. Graph representation of specific activation was obtained by 
plotting total (raw data) minus non-specific (Km=Vmax/2; Km = 33nM for CHO-K1).The 
graph represents data for CHO-K1 cells. D. The specificity of plasminogen binding and 
activation was assessed using Glu-plasminogen supplemented, or not, with 50 mM-ACA, or 
by pre-treatment of CHO-K1 cells with 50 µg/mLcarboxypeptidase B. Plasmin activity was 
completely abolished by 0.5 µM aprotinin. Plasmin formation was measured using 0.75 mM 
CBS0065. Results are expressed in 10
3A405/min (mean  SEM, n = 3). 
 
Figure 2. Early response of cells to plasmin formation: membrane blebbing and 
vesiculation 
CHO-K1,HEK-293 and HMEC-1 cells were incubated with culture medium (CTRL) or with 1 
µM plasminogen (Pg) and supernatants were collected after24 h of incubation. Cell response 
to plasmin was identified by the multiple blebbing of the membrane and vesiculation. A. After 
isolation of these microparticles, their concentration was estimated by measuring the quantity 
of protein (A280nm). B.C.D.The ultra structure of detached cells was observed by electron 
microscopy. Microparticlesare released before any sign of cell death and have a size of around 
300 nm as show at a higher magnification. 
 
Figure 3. Western Blot of microparticles and cell lysate. A. HMEC-1 cells were incubated 
with 1 µM plasminogen and supernatants were collected after24 h of incubation. 
Microparticles were isolated as described in the Experimental section.Western blot analysis of 
uPA (A) and plasminogen kringle1 (B) were performed with lysates ofmicroparticles. C. 
After incubation with culture medium (CTRL), 1µM plasmin (Pn) or 1µM active-site blocked 
plasmin (Pn-VFK), cell lysateand culture supernatant were analysed by Western blot using 
antibodies directed againstlaminin. 
 
Figure 4. Advanced response to plasmin formation: detachment and cell death 
Cells cultured in 96-well plate were incubated with 1 µM plasminogen or culture medium for 
0 or 72 h. A. Optic microscopy after 72h of incubation in the absence (adherent cells, CTRL) 
or presence (detached, rounded cells) of 1 μM plasminogen. B. Quantification of cell death is 
by MTT assay. After activation, detached cells were pulled-down by centrifugation and MTT 
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was added. Bars represents the percentage of living cells (%) as compare to control (without 
plasminogen), n=3±SEM. C. DAPI and TUNEL staining of CHO-K1 cells after incubation 
(72 h) in the presence or absence of 1 μM plasminogen. D. Quantification of TUNEL-positive 
CHO-K1 cells in response to plasminogen exposure for 0 to 72 h. TUNEL index is expressed 
as the percentage of TUNEL-positive nuclei to DAPI-stained nuclei (bars represent mean ± 
SEM, n=3). 
 
Figure 5. Advanced response to plasmin formation: electron microscopy of apoptosis. 
Cells were incubated with plasminogen for 0 to 72 h. A.Electron microscopyof control CHO-
K1 cells. The normal typical characteristics of cells are detectable: normal nucleus (N), 
nucleolus (NL) and cytoplasmic appearance including mitochondria (M) with mitochondrial 
crest, endoplasmic reticulum (RE) and intact membranes. B. After incubation for 48 h with 1 
µM plasminogen morphological features of early apoptosis were observed: change in nucleus 
(N) appearance with chromatin condensation into globular or crescent-shaped forms, and 
formation of lysis vesicles (LV). C. After incubation for 72 h with 1 µM plasminogen 
morphological features of late apoptosis were observed: condensation of mitochondria and 
high chromatin condensation with compaction and fragmentation of the nucleus. 
 
Figure 6. Plasmin-induced cell detachment upon proteolysis of the extracellular matrix. 
Cells were incubated with 1 µM plasmin (Pn) or active-site blocked plasmin (Pn-VFK). 
A.After 48 h of incubation the aminolytic activity of plasmin was assessed by addition of 
CBS0065. Results are expressed in A405/min (mean  SEM, n = 3).B. Quantification of cell 
death by MTT assay. After activation, detached cells were pulled-down by centrifugation and 
MTT was added. Bars represent the percentage of living cells (%) as compare to control 
(without plasmin; mean  SEM, n = 3) 
 
Figure 7. A sequential procedure to analyze membrane blebbing, vesiculation and cell 
apoptosis 
Near confluent adherent cells were incubated with plasminogen. The native tPAor uPA 
expressed by these cells allows detection of plasmin formation from 1h of incubation. The 
plasmin formed at the surface of these cells induces time-dependent responses observed after 
cytospun and fixation of cells: (1) membrane blebbing and vesiculation,and (2) apoptosis. 
Culture supernatants were collected, cytospun and submitted to analysis as indicated in 
methods. 
 
Table 1. From vesiculation to apoptosis 
Summary of main data: plasminogen activator, Km, TUNEL index at 48 h (%), viability at 48 
h (%) and vesiculation (A280) of control (CTRL) and plasminogen treated (Pg) adherent cells. 
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  Activator Km (nM) 
TUNEL index 
at 48 h (%) 
Viabilityat 48 h, 
MTT assay (%) 
Nanovesicles 
(A 280 nm) 
CHO-K1 
CTRL 
tPA 
- 20 99 0.03 
Pg 33 63 42 0.168 
HEK-293 
CTRL 
tPA 
- 18 99 0.04 
Pg 31 45 54 0.157 
HMEC-1 
CTRL 
uPA 
- 13 99 0.01 
Pg 84 83 66 0.106 
 
Table 1 
